Your browser doesn't support javascript.
loading
Failure of alemtuzumab therapy in three patients with MOG antibody associated disease.
Seneviratne, Sinali O; Marriott, Mark; Ramanathan, Sudarshini; Yeh, Wei; Brilot-Turville, Fabienne; Butzkueven, Helmut; Monif, Mastura.
Afiliación
  • Seneviratne SO; Curtin University, Kent Street, Bentley, Perth, WA, 6102, Australia.
  • Marriott M; Department of Neurology, Royal Melbourne Hospital, 300 Grattan Street, Parkville VIC 3050, Australia.
  • Ramanathan S; Department of Neurology, Royal Melbourne Hospital, 300 Grattan Street, Parkville VIC 3050, Australia.
  • Yeh W; Translational Neuroimmunology Group, Kids Neuroscience Centre, The Kids Research Institute at the Children's Hospital, Westmead, NSW, Australia.
  • Brilot-Turville F; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Butzkueven H; Department of Neurology, Concord Hospital, Sydney, Australia.
  • Monif M; Department of Neurology, Alfred Hospital, 55 Commercial Rd, Melbourne, VIC, 3004, Australia.
BMC Neurol ; 22(1): 84, 2022 Mar 09.
Article en En | MEDLINE | ID: mdl-35264149
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neuritis Óptica / Mielitis Transversa Tipo de estudio: Risk_factors_studies Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neuritis Óptica / Mielitis Transversa Tipo de estudio: Risk_factors_studies Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article